Evidence map›Paper›PMID 31694338›Full record

ArticleCancers2019

Lenalidomide Maintenance with or without Prednisone in Newly Diagnosed Myeloma Patients: A Pooled Analysis.

Francesca Bonello, Stefano Pulini, Stelvio Ballanti, Massimo Gentile, Stefano Spada, Ombretta Annibali, Paola Omedé, Sonia Ronconi, Clotilde Cangialosi, Luigi Podda and 14 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Rethinking corticosteroids use in oncology.Frontiers in pharmacology · 2025
    Article
  2. Article
  3. Cost-Effectiveness of Post-Autotransplant Lenalidomide in Persons with Multiple Myeloma.Mediterranean journal of hematology and infectious diseases · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Francesca BonelloMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.
Stefano PuliniU.O. Ematologia Clinica, Dipartimento di Ematologia, Ospedale Civile "Spirito Santo", 65124 Pescara, Italy.
Stelvio BallantiEmatologia con TMO, Ospedale Santa Maria della Misericordia, 06129 Perugia, Italy.
Massimo GentileUOC di Ematologia, AO Cosenza, 87100 Cosenza, Italy.
Stefano SpadaMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.
Ombretta AnnibaliUnit of Hematology, Stem Cell Transplantation, University Campus Bio Medico, 00128 Rome, Italy.
Paola OmedéMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.
Sonia RonconiIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola, Italy.
Clotilde CangialosiDivisione Ematologia UTMO, Azienda Ospedaliera Villa Sofia Cervello, 90146 Palermo, Italy.
Luigi PoddaEmatologia, Azienda Ospedaliero-Universitaria Sassari, 07100 Sassari, Italy.
Angelo PalmasEmatologia, Ospedale S. Francesco, 08100 Nuoro, ATS Sardegna, Italy.
Alessandra MalfitanoMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.
Giulia RivoliHaematology Clinic, Department of Internal Medicine (DiMI), University of Genoa, Policlinico San Martino, IRCCS per l'Oncologia, 16132 Genova, Italy.
Angelo BelottiDivision of Hematology-ASST Spedali Civili di Brescia, 25123 Brescia, Italy.
Fabrizio CiambelliSc Ematologia, ASST Valle Olona, 21052 Busto Arsizio, Italy.
Iolanda Donatella VincelliDivisione di Ematologia, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, 89124 Reggio Calabria, Italy.
Anna Maria CafroDepartment of Oncology and Hematology, Niguarda Ca'Granda Hospital, 20162 Milano, Italy.
Vanessa InnaoDivision of Hematology, Department of Human Pathology and the Adult Developmental, Faculty of Medicine, Messina University, 98122 Messina, Italy.
Antonio PalumboMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.
Pieter SonneveldDepartment of Hematology, Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Andrew SpencerDepartment of Haematology, Alfred Health-Monash University, Melbourne, VIC 3004, Australia.
Roman HájekDepartment of Haematooncology, University Hospital Ostrava, 70852 Ostrava, Czech Republic.
Mario BoccadoroMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.
Francesca GayMyeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, via Genova 3, 10126 Torino, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

lenalidomidemaintenancemultiple myelomanewly diagnosedprednisone

Identifiers

PMID31694338
PMCPMC6896192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.